Key Financial Figures (Rs in Lakhs)
Income Statement:
- Revenue from Operations: ₹271.80 lakh (Q1 FY27) vs ₹223.90 lakh (Q4 FY26) and ₹78.06 lakh (Q1 FY26)
- Interest Income: ₹241.47 lakh
- Fee and Commission Income: ₹21.47 lakh
- Net gain on fair value changes: ₹8.86 lakh
- Other Income: ₹7.34 lakh
- Total Income: ₹279.14 lakh
Expenses:
- Finance Cost: ₹29.31 lakh
- Fees and Commission Expense: ₹4.13 lakh
- Employee Benefits Expense: ₹167.55 lakh
- Depreciation: ₹0.12 lakh
- Other Expenses: ₹12.69 lakh
- Total Expenses: ₹213.80 lakh
Profitability:
- Profit Before Tax: ₹65.34 lakh
- Tax Expense: ₹20.02 lakh
- Current Tax: ₹17.79 lakh
- Deferred Tax: ₹2.23 lakh
- Net Profit for Quarter: ₹45.32 lakh (vs loss of ₹15.93 lakh in Q1 FY26)
- Total Comprehensive Income: ₹76.54 lakh
Earnings Per Share:
- Basic EPS: ₹0.49
- Diluted EPS: ₹0.47
Capital Structure:
- Paid-up Equity Share Capital: ₹922.80 lakh (Face value ₹10 each)
- Other Equity: ₹4,602.62 lakh (as of March 31, 2026)
Historical Context and Corporate Actions
- The company completed a rights issue in the previous year, allotting 33,74,428 equity shares at ₹80 per share (including ₹70 premium), aggregating ₹2,699.54 lakhs
- EPS for comparative periods have been restated in accordance with Ind AS 33 due to the rights issue
- On May 12, 2026, the Nomination and Remuneration Committee approved grant of 24,967 stock options under "TEDGE ESOS 2025" to eligible employees
- Each stock option is convertible into one equity share of face value ₹10
- Diluted EPS computation includes impact of outstanding employee stock options as per Ind AS 33 and Ind AS 102
Additional Information
The company is a Non-Banking Financial Company (NBFC) with no activities other than finance company operations. There are no separate reporting segments as per Ind AS 108.
The results will be available on the BSE website (www.bseindia.com) and company website (www.trustedgecapital.in). The company will publish an extract of the unaudited financial results as required by Regulation 47 of Listing Regulations.